FREERIDE-STUDY Freeway randomized angioplasty study Prospective, Randomized, Controlled, Multicentre, Open Study Release of Paclitaxel during PTA versus PTA alone for the treatment of de-novo occluded, stenotic or reoccluded, restenotic superficial femoral (SFA) or popliteal arteries

Trial Profile

FREERIDE-STUDY Freeway randomized angioplasty study Prospective, Randomized, Controlled, Multicentre, Open Study Release of Paclitaxel during PTA versus PTA alone for the treatment of de-novo occluded, stenotic or reoccluded, restenotic superficial femoral (SFA) or popliteal arteries

Recruiting
Phase of Trial: Phase III

Latest Information Update: 27 Feb 2017

At a glance

  • Drugs Paclitaxel (Primary)
  • Indications Ischaemia; Peripheral arterial disorders
  • Focus Therapeutic Use
  • Acronyms FREERIDE-STUDY
  • Sponsors Eurocor
  • Most Recent Events

    • 17 Sep 2014 Interim results (n=84) presented at the 26th Annual Scientific Symposium on Transcatheter Cardiovascular Therapeutics
    • 26 Aug 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top